Breast cancer (BC) encompasses many challenges for women’s physical and mental health. Lymphedema, pain,1 hot flashes, loss of sexual function,2 and fatigue3 are commonly experienced, and depressive symptoms are more prevalent in women with BC as compared to age-matched women without BC.4 Women with BC commonly experience fears of recurrence5 and evaluate their health-related quality of life (HRQoL) as lower than women without BC.6 Although consequences of BC on mental and physical HRQoL are well-established, it remains unclear how these may affect one another. The present study addresses this gap by evaluating a model of HRQoL in women with BC, focusing on the role of resilience.
Resilience has been found to be a strong predictor of HRQoL in women with BC. It relates to a set of characteristics that enables one to maintain good functioning in face of adversity,7 such as a BC diagnosis. Resilient women with BC experience less distress,8 fatigue,9 depressive and anxiety symptoms, have higher physical functioning,10 and need less social support.11 Thus, resilience seems to be an important factor for both mental and physical HRQoL, although associations with psychological factors are stronger.12 There is a lack of understanding of why resilient women seem to handle their BC better, not only mentally, but also physically. Moreover, resilience seems to be an especially strong predictor of global health and quality of life (QoL), ie women’s self-evaluations of their health and QoL.13 It remains unclear why this may be the case. A recent study in lung cancer suggested that resilience may influence symptom burden through reduced psychological distress.14 It is thus possible that mental HRQoL is a mechanism through which resilience affects physical HRQoL. Another potential mechanism through which resilience may affect both physical and mental HRQoL is increased physical activity. Resilient women may have higher self-efficacy in relation to managing their health,10 which may result in increased physical activity aimed at managing their symptoms and wellbeing. Physical activity during adjuvant treatment has been linked with improved physical functioning and decreased symptoms.15
Several models of resilience and HRQoL in cancer patients have been proposed14,16 but they did not distinguish between mental and physical HRQoL, as well as global QoL. We aimed to separate psychological from physical and global HRQoL components to differentiate their associations with resilience. Mental HRQoL can be defined as consisting of cognitive and emotional components.17 Cognitive functioning relates to memory and focus, whereas emotional functioning relates to the experience of psychological distress, ie symptoms of depression and anxiety.18 In BC, physical HRQoL consists of physical functioning (ie ability to carry out physical tasks) and cancer-specific symptoms.17 Global QoL relates to respondents’ evaluations of health and QoL in general, rather than of specific elements.19
One way of investigating the relationships between resilience, physical HRQoL, mental HRQoL, and global QoL in unison is Structural Equation Modelling (SEM), which allows for a simultaneous analysis of multiple direct and indirect effects. The term “effect” is in this paper used in a statistical, not causal manner.
AimsThe main aim of this study was to investigate the relationships between resilience, physical activity, mental HRQoL, physical HRQoL, and global QoL.
Previous research has found that resilience is a predictor of mental,8,10,13 physical,10,13 and global HRQoL,13 and that physical activity is beneficial for symptom reduction during adjuvant treatment.15 Resilient women have also been found to have higher self-efficacy for managing their health during treatment.10 We therefore propose physical activity could be a mechanism through which resilience affects mental and physical HRQoL. In addition, a recent model of HRQoL in lung cancer found that reduced distress may be a mechanism through which resilience influences symptom burden.14 We thus further propose resilience may affect physical and global QoL through mental HRQoL.
We thus hypothesize the following paths:
Resilience has a direct positive effect on physical activity. Physical activity positively affects both physical and mental HRQoL. Resilience positively affects mental HRQoL directly, and indirectly, via increased physical activity. Resilience positively affects physical HRQoL directly, and indirectly, via increased mental HRQoL and physical activity. Resilience has a direct positive effect on global QoL and an indirect effect through increased mental HRQoL. Mental and physical HRQoL have a direct positive effect on global QoL. Materials and MethodsParticipants and ProcedureThe sample consisted of 638 women with newly diagnosed primary BC residing in southern Sweden. The sample was collected within the ReScreen project, a complex RCT study aimed at enhancing individualized rehabilitation for BC (NCT03434717).20 Patients were allocated to the intervention group, control group or observational group, based on their score on the Distress Thermometer21 at diagnosis. Patients with high distress (≥5) were randomized 1:1 to the intervention or control group, whereas the patients with low distress formed the observational group.20 Primary endpoints include HRQoL, resilience, and distress.21 Sample size evaluation was conducted for the RCT considering distress as the primary outcome. Assuming the same standard deviation (SD), 2.9 units, of the Distress Thermometer scores at the follow-up visit in the two randomized groups, 266 patients, ie 133 per group, were required for a two-sided two-sample t-test to have 80% power to detect a 1.0 unit mean difference. By further assuming that the observation group (distress <5) accounts for 60% of the patients in the study, the required sample size increased to 665.
Data collection for this study was conducted as the baseline measurement for ReScreen. Inclusion was conducted between 2019 and 2022 at the local University and a county hospital. Inclusion criteria were primary BC diagnosis, age ≥ 18, knowledge of Swedish, and cognitive ability to participate. Exclusion criteria were recurrent disease, pregnancy, cognitive impairment, substance abuse, and severe mental illness. Patients who met the inclusion criteria were contacted by the contact nurse at the hospital one to two weeks after diagnosis. The contact nurse provided written and oral information about the study and informed them that participation is voluntary, and that they can withdraw from the study without it affecting their treatment, after which patients signed the consent document. Patients filled in the baseline instruments at the outpatient center. Clinical data were collected from patients’ medical records. Data quality control was conducted according to a predefined monitoring plan.
MeasuresResilienceA latent variable representing resilience was constructed using the items from the Swedish version of the Connor-Davidson Resilience Scale (CD-RISC).22 Both a 25-item and a brief (10-item) form23 of CD-RISC were evaluated. CD-RISC assesses various components of resilience. A summary score is calculated by summarizing scores on all items.24 Participants indicate whether they agree with each statement on a Likert scale from 0 (“Not true at all”) to 4 (“True nearly all the time”). Internal consistency of the 10-item CD-RISC was high (α = 0.88).
Physical ActivityPhysical activity is a latent variable measured using five Likert-based items. Two items assess time one spends weekly doing vigorous and mild exercise on a 6-point and 7-point Likert scale, ranging from “Zero minutes” to “More than 300 minutes” for mild and “More than 120 minutes” for vigorous activity. One item assesses the extent to which one’s work is physically demanding on a 5-point Likert scale. Two items assess time spent on rest during weekdays and the weekend on a 5-point Likert scale, ranging from “Zero to two hours” to “More than eight hours”.
Mental HRQoLA latent variable representing mental HRQoL was constructed using the emotional functioning (EF) and cognitive functioning (CF) subscales from the EORTC Quality of Life Questionnaire-Core 30 (QLQ-C30 version 3.0),25 as well as the future perspective (FP) subscale from the breast cancer module of QLQ (QLQ-BR23)26 and distress thermometer (DT).21 The EF subscale contains four items, assessing how worried, irritable, depressed, and tense one felt during the week prior, whereas the CF subscale contains two items relating to focusing and memory problems. FP includes one item, measuring worry about future health. Items are rated on a 4-point Likert scale. DT contains one item, measuring amount of experienced psychological distress. Internal consistency of EF was high (α = 0.82), and of CF acceptable (α = 0.77).
Physical HRQoLSubscales of QLQ-C3025 were examined to avoid confounding between psychological and physical components of HRQoL. The physical functioning subscale (PF) is the only subscale that relates only to the physical health factor, unlike role functioning (RF) and social functioning (SF), which relate to both physical and mental HRQoL.17 PF is assessed with five items. Participants report on a 4-point Likert scale whether they have trouble performing various physical activities. Internal consistency of PF was acceptable (α = 0.77). From the symptom subscales, nausea and vomiting, dyspnoea, appetite loss, constipation, and diarrhea correspond only to physical health, whereas pain, fatigue, and insomnia correspond to both physical and mental HRQoL.17 Therefore, only the former five symptom subscales were retained.
Global QoLA latent variable representing global QoL was constructed from two items from QLQ-C3025 pertaining to global health status and global QoL. Participants report how they would rate their health and QoL on a 7-point Likert scale. Internal consistency was high (α = 0.88).
Statistical AnalysisFirst, the measurement model containing the specified latent variables was assessed using Confirmatory Factor Analysis (CFA). Next, SEM was used to assess the structural model, including the overall fit of the model and strength of the hypothesized direct and indirect paths. The Yuan-Bentler scaled test statistic was employed as a correction for non-normal distribution of variables. Robust standard errors are reported. The χ2 and incremental (CFI and TLI >.9) and absolute (RMSEA < 0.06 and SRMR < 0.08) goodness-of-fit indices were employed to evaluate model fit.27 Criterion for factor loadings in the measurement model was ≥ 0.4, ie items with at least 16% of the variance explained by the factor were retained. Missing data were handled using Full Information Maximum Likelihood estimation. Overall, participants with missing data (< 5%) were not significantly different on other variables included in the model, indicating data were missing at random (MAR), conditional on the variables included in the model (see Supplementary Tables 1–6). Modification Indices were inspected to guide model refinement. All reported β coefficients are standardized. Software employed to perform the analyses was R version 4.2.228 using the lavaan package.29 Internal consistency was measured by Cronbach’s alpha (α).
ResultsSample CharacteristicsA total of 784 patients were asked to participate, out of which 643 gave their consent. However, three participants were excluded due to not fitting inclusion criteria and two patients withdrew their consent. Participants were women with primary BC aged between 25 and 90. Clinical and sociodemographic characteristics of the sample are presented in Table 1.
Table 1 Socio-Demographic and Clinical Characteristics of the Sample (N = 638)
The Measurement ModelThe prespecified measurement model failed to converge due to negative variances. After inspecting the variables, three items from the physical activity construct were removed as they did not correlate with other physical activity items (see Supplementary Table 7). Items representing amount of mild and vigorous exercise were retained as they were deemed more central to the construct of physical activity than amount of rest. After removing these items, the model converged, but the model fit was poor (χ2(1070) = 3328, p < 0.001; CFI = 0.82, TLI = 0.81, RMSEA = 0.06, SRMR = 0.08). Moreover, some items had factor loadings < 0.4, not meeting the pre-established criterion for factor loadings, namely items 2, 3, and 9 for CD-RISC and items 3, 5, 8, 13, 14, 15 16, and 17 for physical HRQoL. These HRQoL items correspond to cancer-related symptoms that few patients experienced, hence likely not having much clinical value at this stage of the cancer process, prior to treatment. These items were removed. Thus, only physical functioning (PF) items were retained for physical HRQoL. Subsequently, the overall model fit was better but still not satisfactory (χ2(619) = 1974, p < 0.001; CFI = 0.87, TLI = 0.86, RMSEA = 0.06, SRMR = 0.06). After inspecting Modification Indices, it was noted that many of the CD-RISC items correlated very highly, suggesting redundancy in the items. The measurement model with the ten-item form of CD-RISC23 was tested, as it is a validated and authorized form of the instrument, with value for clinical use due to its brevity. This model had a good model fit (χ2(265) = 678, p < 0.001; CFI = 0.93 (>.9), TLI = 0.93, RMSEA = 0.05, SRMR = 0.04) and all items had loadings > 0.4. Means, standard deviations, and correlations between all subscales are presented in Table 2.
Table 2 Means, Standard Deviations, and Pearson Correlations Between the Subscales and Scales Included in the Model (N = 638)
The Structural ModelThe hypothesized structural model achieved good fit (χ2(266) = 678, p < 0.001; CFI = 0.93, TLI = 0.93, RMSEA = 0.05, SRMR = 0.05). However, examination of the structural paths suggested that physical activity did not have a direct effect on mental HRQoL (β = 0.07, p = 0.22), and resilience did not have an indirect effect on mental HRQoL via physical activity (β = 0.02, p = 0.23). Resilience also did not have a direct effect on global QoL (β = 0.07, p = 0.10) or PF (β = −0.06, p = 0.38).
The non-significant structural paths were removed to maximize fit and parsimony of the model. This simplified model was tested and had good model fit (χ2(269) = 684, p < 0.001; CFI = 0.93, TLI = 0.93, RMSEA = 0.05, SRMR = 0.05). Resilience had a moderate positive effect on physical activity and a moderate-to-strong positive effect on mental HRQoL. Physical activity had a moderate-to-strong positive effect on PF. Mental HRQoL had a weak positive effect on PF. PF had a moderate positive effect on global QoL, whereas mental HRQoL had a strong positive effect on global QoL (Table 3).
Table 3 Indirect and Direct Effects of Independent Variables (Columns) on the Outcome Variables (Rows) in the Final Model
The final model is presented in Figure 1 where rectangles represent manifest variables, circles latent variables, and single-headed arrows significant direct effects of one variable on another. Although resilience did not have a direct effect on PF and global QoL, it had a small positive indirect effect on PF via increased mental HRQoL and increased physical activity, as well as a moderate positive indirect effect on global QoL via increased mental HRQoL (Table 3). The model explained 67% of the variance in global QoL.
Figure 1 Structural equation model of HRQoL in a sample of newly diagnosed breast cancer patients.
Abbreviations: EORTC, European Organization for Research and Treatment of Cancer; CD-RISC, Connor-Davidson Resilience Scale; BR23, Breast Cancer Module.
Note: All coefficients are standardized.
DiscussionThe aim of this study was to evaluate a model of HRQoL in women with newly diagnosed BC. To our knowledge, this is the first study that elucidates the potential pathways through which resilience may influence mental HRQoL, physical functioning, and global QoL in women with primary BC at diagnosis. Previous research has highlighted resilience as a predictor of psychological components such as psychological distress,8 depressive and anxiety symptoms,10 and mental HRQoL13 in women with BC. In this study, the relationship between resilience and mental HRQoL was direct and moderate-to-strong, in line with previous research.30 Highly resilient women seem more likely to maintain high mental HRQoL after receiving a BC diagnosis, either due to perceiving the situation as less stressful, or by utilizing effective coping mechanisms to manage the stress.31
We also found that resilience was positively associated with physical activity, supporting the hypothesis that resilient women may be more motivated to be physically active, possibly due to higher self-efficacy.10 Surprisingly, physical activity was not associated with mental HRQoL in our sample, unlike in previous research in women with BC30 and healthy individuals.32 It is possible this is due to the specific time frame in which the data were collected, ie right after diagnosis. While it is likely that physical activity plays a role in mental HRQoL during BC treatment and survivorship, it is possible that physical activity does not attenuate the emotional impact of receiving the diagnosis in the short term. It would be of interest to investigate this relationship longitudinally. As hypothesized, physical activity had a moderate-to-strong effect on physical functioning.
Further, we found no direct relationship between resilience and physical functioning, nor between resilience and global QoL. These associations were found in previous research.10,13 Nevertheless, we found indirect relationships between resilience and physical functioning (via physical activity and mental HRQoL) and resilience and global QoL (via MHRQoL). This suggests that resilient women with BC may experience better physical functioning due to increased physical activity and increased mental HRQoL, and evaluate their health and QoL as higher due to experiencing better mental HRQoL, as hypothesized. Therefore, this study expands on previous research by suggesting potential mechanisms that may explain previously reported associations between resilience and physical functioning as well as global QoL in BC patients.
We tried to distinguish between physical and psychological components of HRQoL to differentiate the nature of the relationship between resilience and these outcomes in BC. Doing so, we excluded role functioning, which is in some studies considered a physical HRQoL component,33 and in others both psychological and physical.17 In QLQ-C30, role functioning encompasses one’s ability to pursue work and leisure time activities.25 As this ability can be restricted by psychological difficulties as well as physical, we adopted the more conservative interpretation of role functioning.17 Role functioning was previously found to be associated with resilience13 in BC patients. It would thus be of interest to further explore the factors that may impact this relationship. Furthermore, the symptom subscales did not load on the same factor, probably due to the participants not yet experiencing treatment side-effects, resulting in very few patients reporting any symptoms. It is possible that the symptom items would load on the same factor if measured after treatment, as suggested by a study on more advanced lung cancer patients.14 In that study, resilience was found to affect symptom burden via distress, and it would be beneficial to explore this further in later stages of BC when symptoms are more prominent. Further, including only the ten items from the brief version of CD-RISC23 resulted in a better model fit. This is in line with some previous investigations that suggested that shorter versions of the scale perform just as well or better than the 25-item version.34,35 The ten-item version of CD-RISC has been validated and authorized.24
The study had several limitations. It is impossible to make inferences about causal effects between the study variables as the sample was cross-sectional and SEM does not allow for making causal inferences. Further, the time right after diagnosis is important as women experience shock and high uncertainty,36 but the chosen time frame of data collection implies that the findings cannot be generalized to women in later stages of their BC experience. Both of these limitations can be addressed to an extent by replicating the study longitudinally in order to encompass all stages of the BC continuum. Further, HRQoL is a complex construct. Social and clinical factors such as financial status and BC stage likely play a role in the HRQoL. The relatively small sample size of the study did not permit investigating all potential factors of HRQoL. However, comprehensive models of HRQoL should include a combination of biopsychosocial factors. Future research should focus on later stages of BC, allowing for inclusion of symptom burden, as well as socio-economic factors, treatment modalities, and tumor characteristics in a broader model of HRQoL. The findings on the relationship between mental HRQoL, physical activity, and resilience should be further explored longitudinally.
Clinical ImplicationsThe study findings can help enhance rehabilitation for BC patients by illuminating areas which need to be prioritized. In rehabilitation, it is often difficult to target the main issues that patients report. This study proposes potential precursors to these issues which could be targeted, namely resilience, physical activity, and mental HRQoL. The study suggests that support aimed at the reduction of psychological distress may be beneficial in managing not only distress, but ultimately physical functioning and global QoL.
ConclusionThis study provided further evidence for the importance of resilience as a protective factor for maintaining high HRQoL right after receiving a BC diagnosis. Resilience can be easily assessed, and women who may not be highly resilient can be identified early in the BC process and provided appropriate support, mainly focusing on managing emotional distress and encouraging physical activity, which may have an ensuing effect on other aspects of HRQoL. The study should be replicated in longitudinal samples.
Data Sharing StatementThe datasets generated and analysed during this study are not publicly available due to privacy restrictions made by the Ethical Review Authority but are available from the corresponding author on reasonable request.
Ethics Approval and Informed ConsentAn ethical approval was obtained for the study from the Swedish Ethical Review Authority (Dnr 2015/505). The study was conducted in accordance with the ethical guidelines established in the Helsinki Declaration. All participants provided written informed consent.
Consent for PublicationDistress Thermometer referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Distress Management V.1.2024. © National Comprehensive Cancer Network, Inc. 2023. All rights reserved. Accessed [January 15, 2024]. To view the most recent and complete version of the guidelines, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
AcknowledgmentsWe would like to express our gratitude to all patients who participated in the study, and research nurse Helena Erixon for delivering the intervention. We would also like to thank both Helena Erixon and administrator Eva Wahlström for their efforts in collecting data. Finally, we want to thank the contact nurses at the BC unit who recruited participants to the study.
Author ContributionsAll authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.
FundingThe ReScreen study was funded in part by external funding through governmental funding of clinical research within the Swedish National Health Service (grant number: 200-Projekt0190), FORTE (grant number: 2020-00105), the Swedish Breast Cancer Association (no grant number), the Cancer and Allergy Foundation (grant number: 220) and the Swedish Cancer Society (grant number: 230656FE). The funding bodies had no role in any components, from study design, to submission for publication. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript (AAM) version arising from this submission.
DisclosureThe authors report no conflicts of interest in this work.
References1. Byun HK, Chang JS, Im SH, et al. Risk of lymphedema following contemporary treatment for breast cancer: an analysis of 7617 consecutive patients from a multidisciplinary perspective. Ann Surg. 2021;274(1):170–178. doi:10.1097/SLA.0000000000003491
2. Castillo H, Mension E, Cebrecos I, Anglès S, Castelo-Branco C. Sexual function in breast cancer patients: a review of the literature. Clin Exp Obstet Gynecol. 2022;49(6):134. doi:10.31083/j.ceog4906134
3. Jackson C, Freeman ALJ, Szlamka Z, Spiegelhalter DJ. The adverse effects of bisphosphonates in breast cancer: a systematic review and network meta-analysis. PLoS One. 2021;16. doi:10.1371/journal.pone.0246441
4. Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst. 2012;104(5):386–405. doi:10.1093/jnci/djr541
5. Zhang X, Sun D, Qin N, Liu M, Jiang N, Li X. Factors correlated with fear of cancer recurrence in cancer survivors: a meta-analysis. Cancer Nurs. 2022;45(5):406–415. doi:10.1097/NCC.0000000000001020
6. Mohlin Å, Bendahl P, Hegardt C, Richter C, Rahm Hallberg I, Ryden L. Psychological resilience and health-related quality of life in 418 Swedish women with primary breast cancer: results from a prospective longitudinal study. Cancers. 2021;13:2233. doi:10.3390/cancers13092233
7. Fletcher D, Sarkar M. Psychological resilience: a review and critique of definitions, concepts and theory. Eur Psychol. 2013;18(1):12–23. doi:10.1027/1016-9040/a000124
8. Harms CA, Cohen L, Pooley JA, Chambers SK, Galvao DA, Newton RU. Quality of life and psychological distress in cancer survivors: the role of psycho-social resources for resilience. Psycho-Oncol. 2017;28:271–277. doi:10.1002/pon.4934
9. Brix C, Schleussner C, Fuller J, Rohrig B, Strauss B. Fatigue and its determinants in radio-oncology. Psychother Psychosom Med Psychol. 2009;59:42–49. doi:10.1055/s-2008-1067341
10. Schumacher A, Sauerland C, Silling G, Berdel WE, Stelljes M. Resilience in patients after allogeneic stem cell transplantation. Support Care Cancer. 2013;22:487–493. doi:10.1007/s00520-013-2001-6
11. Brix C, Schleussner C, Fuller J, Roehrig B, Wendt TG, Strauss B. The need for psychosocial support and its determinants in a sample of patients undergoing radiooncological treatment of cancer. J Psychosom Res. 2008;65:541–548. doi:10.1016/j.jpsychores.2008.05.010
12. Hu T, Zhang D, Wang J. A meta-analysis of the trait resilience and mental health. Pers Individ Differ. 2015;76:18–27. doi:10.1016/j.paid.2014.11.039
13. Velickovic K, Borrebaeck CAK, Bendahl P-O, et al. One-year recovery from breast cancer: importance of tumor and treatment-related factors, resilience, and socio-demographic factors for health-related quality of life. Front Oncol. 2022;12:891850.
14. Lee JL, Jeong Y. Quality of life in patients with non-small cell lung cancer: structural equation modeling. Cancer Nurs. 2019;42(6):475–483. doi:10.1097/NCC.0000000000000645
15. Van Waart H, Stuiver MM, van Harten WH, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33(17):1918–1927. doi:10.1200/JCO.2014.59.1081
16. Firouzbakht M, Hajian-Tilaki K, Moslemi D. Analysis of quality of life in breast cancer survivors using structural equation modelling: the role of spirituality, social support and psychological well-being. Int Health. 2020;12(4):354–363. doi:10.1093/inthealth/ihz108
17. Gundy CM, Fayers PM, Groenvold M, et al. Comparing higher order models for the EORTC QLQ-C30. Qual Life Res. 2012;21:1607–1617. doi:10.1007/s11136-011-0082-6
18. Mirowsky J, Ross CE. Selecting outcomes for the sociology of mental health: issues of measurement and dimensionality. J Health Soc Behav. 2002;43:152–170. doi:10.2307/3090194
19. Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18(7):873–880. doi:10.1007/s11136-009-9496-9
20. Olsson Möller U, Olsson I-M, Sjövall K, Beck I, Rydén L, Malmström M. Systematic screening as a tool for individualized rehabilitation following primary breast cancer treatment: study protocol for the ReScreen randomized controlled trial. BMC Cancer. 2020;20:484. doi:10.1186/s12885-020-06815-3
21. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: distress management, version 1. 2024. Available from: https://www.nccn.org/guidelines/. Accessed October24, 2024.
22. Connor KM, Davidson JR. Development of a new resilience scale: the Connor–Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76–82. doi:10.1002/da.10113
23. Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the Connor-Davidson resilience scale (CD-RISC): validation of a 10-item measure of resilience. J Trauma Stress. 2007;20(6):1019–1028. doi:10.1002/jts.20271
24. Davidson JRT. Connor-Davidson Resilience Scale (CDRISC) manual. Unpublished. 2020. Available from: www.cdrisc.com. Accessed January1, 2020.
25. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376. doi:10.1093/jnci/85.5.365
26. Sprangers MAG, Groenvold M, Arraras JI, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality of life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14:2756–2768. doi:10.1200/JCO.1996.14.10.2756
27. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equation Model. 1999;6(1):1–55. doi:10.1080/10705519909540118
28. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2022.
29. Rosseel Y. lavaan: an R package for structural equation modeling. J Stat Softw. 2012;48(2):1–36. doi:10.18637/jss.v048.i02
30. Matzka M, Mayer H, Köck-Hódi S, et al. Relationship between resilience, psychological distress and physical activity in cancer patients: a cross-sectional observation study. PLoS One. 2016;11(4):e0154496. doi:10.1371/journal.pone.0154496
31. Borgi M, Collacchi B, Ortona E, Cirulli F. Stress and coping in women with breast cancer: unravelling the mechanisms to improve resilience. Neurosci Biobehav Rev. 2020;119:406–421. doi:10.1016/j.neubiorev.2020.10.011
32. Singh B, Olds T, Curtis R, et al. Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews. Br J Sports Med. 2023;57(18):1203–1209. doi:10.1136/bjsports-2022-106195
33. Faller H, Brähler E, Härter M, et al. Performance status and depressive symptoms as predictors of quality of life in cancer patients. a structural equation modeling analysis. Psycho-Oncol. 2015;24(11):1456–1462. doi:10.1002/pon.3811
34. Gonzales SP, Moore EW, Newton M, Galli NA. Validity and reliability of the Connor-Davidson resilience scale (CD-RISC) in competitive sport. Psychol Sport Exerc. 2016;23:31–39. doi:10.1016/j.psychsport.2015.10.005
35. Campbell-Sills L, Cohan SL, Stein MB. Relationship of resilience to personality, coping, and psychiatric symptoms in young adults. Behav Res Ther. 2006;44:585–599. doi:10.1016/j.brat.2005.05.001
36. Ciria-Suarez L, Jiménez-Fonseca P, Palacín-Lois M, et al. Breast cancer patient experiences through a journey map: a qualitative study. PLoS One. 2021;16(9):e0257680. doi:10.1371/journal.pone.0257680
留言 (0)